Symbols / IPA
IPA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-12 08:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
News
RSS: Latest IPA news- New MindWalk (NASDAQ: HYFT) B Cell Llama platform targets bispecific and cell therapies - Stock Titan Fri, 06 Mar 2026 21
- ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - MSN Sat, 07 Mar 2026 07
- This Penny Stock Has Wall Street's Attention and Is Up Nearly 600% - Yahoo Finance Fri, 22 Aug 2025 07
- HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView Mon, 15 Dec 2025 08
- Digest: IPA Census 2025 Shows Staff Decline & Diversity Gains; Amazon Eyes Marketplace for AI Content Deals; Spotify Profits Soar After Raising Prices - exchangewire.com hu, 12 Feb 2026 09
- ImmunoPrecise evolves into MindWalk to reflect AI-focused future - Fierce Pharma hu, 04 Sep 2025 07
- ImmunoPrecise (IPA) Advances Universal Dengue Vaccine Developmen - GuruFocus ue, 24 Jun 2025 07
- H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Mon, 14 Apr 2025 07
- Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st ue, 22 Apr 2025 07
- ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance ue, 29 Jul 2025 07
- Revolutionary AI Creates Superior GLP-1 Drug: Beats Ozempic Maker's Semaglutide in Laboratory Tests - Stock Titan hu, 12 Jun 2025 07
- Strategic Acquisition: AVS Bio Expands Global Biologics Reach with ImmunoPrecise Europe Buyout - Stock Titan Wed, 06 Aug 2025 07
- ImmunoPrecise Antibodies’ LENSai Platform Achieves Breakthrough in Epitope Mapping Accuracy - Yahoo Finance Sun, 06 Jul 2025 07
- We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate - Yahoo Finance Wed, 18 Jun 2025 07
- New 9% 'Big Trip' IPA rides Southeast double-IPA demand - Stock Titan hu, 22 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for IPA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|